Evidence map›Paper›PMID 26744368›Full record

ArticleGenome announcements2016

Draft Genomes for Eight Burkholderia mallei Isolates from Turkey.

H E Daligault, S L Johnson, K W Davenport, T D Minogue, K A Bishop-Lilly, S M Broomall, D C Bruce, S R Coyne, K G Frey, H S Gibbons and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genome announcements, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. First record of Burkholderia mallei Turkey 10 strain originating from glanderous horses from Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

H E DaligaultLos Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.
S L JohnsonLos Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA shannonj@lanl.gov.ORCID http://orcid.org/0000-0002-3972-9208
K W DavenportLos Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.
T D MinogueUnited States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.
K A Bishop-LillyNaval Medical Research Center (NMRC), Frederick, Fort Detrick, Maryland, USA Henry M. Jackson Foundation, Bethesda, Maryland, USA.
S M BroomallUnited States Army Edgewood Chemical Biological Center (ECBC), Aberdeen Proving Ground, Aberdeen, Maryland, USA.
D C BruceLos Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.
S R CoyneUnited States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.
K G FreyNaval Medical Research Center (NMRC), Frederick, Fort Detrick, Maryland, USA Henry M. Jackson Foundation, Bethesda, Maryland, USA.
H S GibbonsUnited States Army Edgewood Chemical Biological Center (ECBC), Aberdeen Proving Ground, Aberdeen, Maryland, USA.
J JaissleUnited States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.
G I KorolevaUnited States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.
J T LadnerUnited States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.
C-C LoLos Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.
C MunkLos Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.
M J WolcottUnited States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.
G F PalaciosUnited States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA.
C L ReddenNaval Medical Research Center (NMRC), Frederick, Fort Detrick, Maryland, USA Henry M. Jackson Foundation, Bethesda, Maryland, USA.
C N RosenzweigUnited States Army Edgewood Chemical Biological Center (ECBC), Aberdeen Proving Ground, Aberdeen, Maryland, USA.
M B ScholzLos Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA Michigan State University (MSU), East Lansing, Michigan, USA.
P S ChainLos Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Burkholderia mallei, the etiologic agent of glanders, is a Gram-negative, nonmotile, facultative intracellular pathogen. Although glanders has been eradicated from many parts of the world, the threat of B. mallei being used as a weapon is very real. Here we present draft genome assemblies of 8 Burkholderia mallei strains that were isolated in Turkey.

Identifiers

PMID26744368
PMCPMC4706339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.